NCI-H1650产品图

NCI-H1650

收藏
  • 询价
  • 2026年05月29日
    avatar
    15 年金牌会员
  • 企业认证

    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 物种来源:

      人

    • 是否是肿瘤细胞:

      1

    • 相关疾病:

      其他疾病

    • ATCC Number:

      CRL-5883™

    • 年限:

      stage 3B

    • 运输方式:

      冻存运输

    • 细胞形态:

      上皮样

    • 器官来源:

      肺

    • 库存:

      大量

    • 生长状态:

      贴壁生长

    Designations: NCI-H1650 [H-1650, H1650]
    Depositors:  AF Gazdar, JD Minna
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: lung
    Tumor Stage: stage 3B
    Disease: adenocarcinoma; bronchoalveolar carcinoma
    Derived from metastatic site: pleural effusion
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Restrictions: The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. A. Gazdar and Dr. J. Minna and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 699-8056, FAX (214) 688-7233.
    Isolation: Isolation date: May, 1987
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 11
    D13S317: 11
    D16S539: 11,12
    D5S818: 11
    D7S820: 8,9
    THO1: 9.3
    TPOX: 11
    vWA: 18
    GenoType: EGFR (DelE746A750) [90471 ]
    Age: 27 years
    Gender: male
    Ethnicity: Caucasian, White
    Comments: The patient was a smoker.
    10 pack years.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

    Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended
    Medium Renewal: Every 2 to 3 days
    Preservation: Freeze medium: Complete growth medium supplemented with 5% DMSO
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    References: 23570: . NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996..
    90471: Sordella R, et al. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163-1167, 2004. PubMed: 15284455

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标询价记录
    图标暂无询价记录
    图标文献和实验
    相关实验
    • 流式细胞仪检测细胞凋亡率案例分析报告

      一、实验材料NCI-H1299,购自上海晶莱生物技术有限公司。表 2.1.1 主要试剂试剂与耗材厂家(货号)细胞培养瓶FALCON 中国(353014)Penicillin/streptomycin solution(KGY002)0.25% Tripsin-EDTA(BK-E3076)PBS(BK330-2)胎牛血清GIBCO 美国(10270-106)1640 培养基Hyclone 美国(SH3080901)Annexin V-FITC/PI 凋亡试剂盒 二、实验仪器表 2.2.1 主要

    • NCI-H446人小细胞肺癌细胞培养全攻略:从基本信息到实操要点

      做小细胞肺癌研究的朋友,对NCI-H446这个细胞系一定不陌生。这篇文章把它的来源、特性、培养要点都梳理了一遍,新手也能快速上手。   细胞系名称与来源   细胞名称:NCI-H446(人小细胞肺癌细胞),也常简称H446。   别称:H-446、NCI-446、NCIH446。   来源:1982年由Carney和Gazdar等人从一位61岁白人男性小细胞肺癌患者的胸腔积液中分离建系。值得一提的是,原始肿瘤的形态并不符合典型小细胞肺癌的特征。   细胞特性与应用场景   NCI-H446属于

    • 论文造假又现身,学术纠错何时了?

      2017 年 8 月 31 日,山东烟台毓璜顶医院呼吸内科邹慎春为第一作者和通讯作者 Yao Zhang 在《分子医学报告》(Molecular Medicine Reports)发表题为《Epicatechin induces apoptotic and autophagic cell death in NCI-H2172 non‑ small cell lung cancer cells along with concomitant mitochondrial membrane

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1320
    博辉生物科技(广州)有限公司
    2025年11月20日询价
    ¥1480
    上海酶研生物科技有限公司
    2026年01月07日询价
    ¥1280
    上海康朗生物科技有限公司
    2026年09月28日询价
    ¥2200
    上海钰博生物科技有限公司
    2026年07月20日询价
    ¥800
    上海沪震实业有限公司
    2025年08月04日询价
    NCI-H1650
    询价